The DFA Discussion, page-74

  1. 165 Posts.
    lightbulb Created with Sketch. 16
    Does anybody think the SHORE trial is going to show anything better Top Line?
    I appreciate it’s a bit of a crystal ball gaze - but I’m
    sure there are those on here who have a considered view on Ranibzumab versus Aflibercert as a combination agent and as a SOC.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.